Hereditary neutropenia: Dogs explain human neutrophil elastase mutations

Trends in Molecular Medicine

Volumn 10, Issue 4, 2004, Pages 163-170

  Horwitz, Marshall ^a   Benson, Kathleen F ^a   Duan, Zhijun ^a   Li, Feng Qian ^a   Person, Richard E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN COMPLEX 3 B1; BLOOD CLOTTING FACTOR 5; GENE PRODUCT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTEGRIN; LEUKOCYTE ELASTASE; MEMBRANE PROTEIN; NOTCH RECEPTOR; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ALGORITHM; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; BETA CHAIN; BONE MARROW; CARBOXY TERMINAL SEQUENCE; CARDIOMYOPATHY; CATALYSIS; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; DNA SEQUENCE; DOG; DROSOPHILA; ELECTRON MICROSCOPY; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE TARGETING; GENETIC DISORDER; GENETIC LINKAGE; GOLGI COMPLEX; GRAY COLLIE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; LINKAGE ANALYSIS; MACROPHAGE; MENTAL DEFICIENCY; MITOCHONDRIAL MEMBRANE; MOLECULAR CLONING; MONOCYTE; MYELODYSPLASIA; NEUTROPENIA; NEUTROPHIL; NONHUMAN; OCULAR ALBINISM; PATHOGENESIS; PHENOTYPE; REVIEW;

ADAPTOR PROTEIN COMPLEX 3; ADAPTOR PROTEIN COMPLEX BETA SUBUNITS; ANIMALS; CELL MEMBRANE; DISEASE MODELS, ANIMAL; DOGS; HUMANS; LEUKOCYTE ELASTASE; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MUTATION; NEUTROPENIA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; TIME FACTORS;

CANIS FAMILIARIS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 1642619057     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.02.002     Document Type: Review

References (73)

1. Morley A.A., et al. Familial cyclical neutropenia. Br. J. Haematol. 13:1967;719-738.
2. Lange R.D. Cyclic hematopoiesis: human cyclic neutropenia. Exp. Hematol. 11:1983;435-451.
3. Horwitz M., et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat. Genet. 23:1999;433-436.
4. Horwitz M., et al. Leukemia in severe congenital neutropenia: defective proteolysis suggests new pathways to malignancy and opportunities for therapy. Cancer Invest. 21:2003;577-585.
5. Dale D.C., et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 96:2000;2317-2322.
6. Aprikyan A.A., et al. Retraction of Aprikyan et al. Blood. 103:2004;389.
7. Bernard T., et al. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br. J. Haematol. 101:1998;141-149.
8. Bellane Chantelot C., et al. The presence of an ELA2 mutation correlates with a more severe expression of neutropenia: study of 81 patients from the French severe chronic neutropenia register. Blood. 102:2003;273a.
9. Ancliff P.J., et al. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood. 98:2001;2645-2650.
10. Ancliff P.J., et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood. 100:2002;707-709.
11. Kawaguchi H., et al. Dysregulation of transcriptions in primary granule constituents during myeloid proliferation and differentiation in patients with severe congenital neutropenia. J. Leukoc. Biol. 73:2003;225-234.
12. Ozsoylu S. Neutrophil elastase gene mutations in cyclic neutropenia. Turk. J. Pediatr. 43:2001;180.
13. Germeshausen M., et al. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Br. J. Haematol. 115:2001;222-224.
14. Benson K.F., Horwitz M. Possibility of somatic mosaicism of ELA2 mutation overlooked in an asymptomatic father transmitting severe congenital neutropenia to two offspring. Br. J. Haematol. 118:2002;923.
15. Germeshausen M., et al. Reply to Benson and Horwitz. Br. J. Haematol. 118:2002;923-924.
16. Duan Z., Horwitz M. Gfi-1 oncoproteins in hematopoiesis. Hematology. 8:2003;339-344.
17. Karsunky H., et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat. Genet. 30:2002;295-300.
18. Hock H., et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity. 18:2003;109-120.
19. Person R.E., et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat. Genet. 34:2003;308-312.
20. Duan Z., Horwitz M. Targets of the transcriptional repressor oncoprotein Gfi-1. Proc. Natl. Acad. Sci. U. S. A. 100:2003;5932-5937.
21. Bieth J.G. Leukocyte elastase. Barrett A.J., et al. Handbook of Proteolytic Enzymes. 1998;54-60 Academic Press.
22. Adkison A.M., et al. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest. 109:2002;363-371.
23. Salvesen G., Enghild J.J. An unusual specificity in the activation of neutrophil serine proteinase zymogens. Biochemistry. 29:1990;5304-5308.
24. Gullberg U., et al. Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J. Biol. Chem. 270:1995;12912-12918.
25. Li F.Q., Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J. Biol. Chem. 276:2001;14230-14241.
26. Benson K.F., et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat. Genet. 35:2003;90-96.
27. Lothrop C.D. Jr, et al. Cyclic hormonogenesis in gray collie dogs: interactions of hematopoietic and endocrine systems. Endocrinology. 120:1987;1027-1032.
28. Dell'Angelica E.C., et al. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol. Cell. 3:1999;11-21.
29. Huizing M., et al. Nonsense mutations in ADTB3A cause complete deficiency of the beta 3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Pediatr. Res. 51:2002;150-158.
30. Clark R.H., et al. Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse. Nat. Immunol. 4:2003;1111-1120.
31. Huizing M., et al. Hermansky-Pudlak syndrome: vesicle formation from yeast to man. Pigment Cell Res. 15:2002;405-419.
32. Starcevic M., et al. The molecular machinery for the biogenesis of lysosome-related organelles: lessons from Hermansky-Pudlak syndrome. Semin. Cell Dev. Biol. 13:2002;271-278.
33. Li W., et al. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat. Genet. 35:2003;84-89.
34. Boehm M., Bonifacino J.S. Genetic analyses of adaptin function from yeast to mammals. Gene. 286:2002;175-186.
35. Obermuller S., et al. The tyrosine motifs of Lamp 1 and LAP determine their direct and indirect targetting to lysosomes. J. Cell Sci. 115:2002;185-194.
36. Griffiths G.M., Isaaz S. Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor. J. Cell Biol. 120:1993;885-896.
37. Feng L., et al. The β3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum. Mol. Genet. 8:1999;323-330.
38. Yang W., et al. Defective organellar membrane protein trafficking in Ap3b1-deficient cells. J. Cell Sci. 113:2000;4077-4086.
39. Aguilar R.C., et al. Signal-binding specificity of the μ4 subunit of the adaptor protein complex AP-4. J. Biol. Chem. 276:2001;13145-13152.
40. Bode W., et al. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry. 28:1989;1951-1963.
41. Aoki Y. Crystallization and characterization of a new protease in mitochondria of bone marrow cells. J. Biol. Chem. 253:1978;2026-2032.
42. Kolkenbrock H., et al. Activation of progelatinase B by membranes of human polymorphonuclear granulocytes. Biol. Chem. 381:2000;49-55.
43. Owen C.A., et al. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131:1995;775-789.
44. Clark J.M., et al. Elastase-like enzymes in human neutrophils localized by ultrastructural cytochemistry. J. Cell Biol. 84:1980;102-119.
45. Cai T.Q., Wright S.D. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion. J. Exp. Med. 184:1996;1213-1223.
46. Allen D.H., Tracy P.B. Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface. J. Biol. Chem. 270:1995;1408-1415.
47. Kaup M., et al. Processing of the human transferrin receptor at distinct positions within the stalk region by neutrophil elastase and cathepsin G. Biol. Chem. 383:2002;1011-1020.
48. Bristow C.L., et al. HIV-1 preferentially binds receptors co-patched with cell surface elastase. Blood. 102:2003;4479-4486.
49. Korkmaz B., et al. Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Am J. Respir. Cell Mol. Biol. 2003;. doi:10.1165/rcmb.2003-0139OC ( http://ajrcmb.atsjournals.org ).
50. Le Borgne R., et al. The mammalian AP-3 adaptor-like complex mediates the intracellular transport of lysosomal membrane glycoproteins. J. Biol. Chem. 273:1998;29451-29461.
51. Faundez V.V., Kelly R.B. The AP-3 complex required for endosomal synaptic vesicle biogenesis is associated with a casein kinase Iα-like isoform. Mol. Biol. Cell. 11:2000;2591-2604.
52. Drake M.T., et al. The assembly of AP-3 adaptor complex-containing clathrin-coated vesicles on synthetic liposomes. Mol. Biol. Cell. 11:2000;3723-3736.
53. Faundez V., et al. A function for the AP3 coat complex in synaptic vesicle formation from endosomes. Cell. 93:1998;423-432.
54. Li F.Q., et al. Lymphoid enhancer factor-1 (LEF-1) links two hereditary Leukemia syndromes through CBFalpha regulation of ELA2. J. Biol. Chem. 279:2003;2873-2884.
55. Grenda D.S., et al. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis. Blood. 100:2002;3221-3228.
56. Bione S., et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat. Genet. 12:1996;385-389.
57. Vreken P., et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279:2000;378-382.
58. Chandler K.E., et al. Diagnostic criteria, clinical characteristics, and natural history of Cohen syndrome. J. Med. Genet. 40:2003;233-241.
59. Kolehmainen J., et al. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am. J. Hum. Genet. 72:2003;1359-1369.
60. Horwitz M., et al. Role of neutrophil elastase in bone marrow failure syndromes: molecular genetic revival of the chalone hypothesis. Curr. Opin. Hematol. 10:2003;49-54.
61. El Ouriaghli F., et al. Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis. Blood. 101:2003;1752-1758.
62. Hunter M.G., et al. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor. Am. J. Hematol. 74:2003;149-155.
63. Carter C.R., et al. The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation. J. Leukoc. Biol. 75:2003;1-8.
64. Levesque J.P., et al. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp. Hematol. 31:2003;109-117.
65. Duan Z., et al. A novel Notch protein, N2N, targeted by neutrophil elastase and implicated in hereditary neutropenia. Mol. Cell. Biol. 24:2004;58-70.
66. Mumm J.S., Kopan R. Notch signaling: from the outside in. Dev. Biol. 228:2000;151-165.
67. Nakagami Y., et al. Loss of TRF2 by radiation-induced apoptosis in HL60 cells. Radiat. Med. 20:2002;121-129.
68. Massullo P., et al. Aberrant processing and subcellular localization of the G185R neutrophil elastase mutation induces apoptosis of differentiating but not proliferating myeloid progenitor cells in severe congenital neutropenia. Blood. 102:2003;9a.
69. Ley T.J., Lane A.A. Neutrophil elastase cleaves PML-RARα and is important for the development of acute promyelocytic leukemia in mice. Cell. 115:2003;305-318.
70. Bangalore N., Travis J. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G. Biol. Chem. Hoppe Seyler. 375:1994;659-666.
71. Kraut J. Serine proteases: structure and mechanism of catalysis. Annu. Rev. Biochem. 46:1977;331-358.
72. Persson B., Argos P. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J. Mol. Biol. 237:1994;182-192.
73. Navia M.A., et al. Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7-11.